USD 10.64
(-4.83%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Operating Cash Flow | 8.45 Million | -28.7 Million | -68.66 Million | -44.12 Million | -61.79 Million |
Net Income | -47.32 Million | -101.28 Million | -199.64 Million | -101.24 Million | -93.54 Million |
Depreciation & Amortization | 35.91 Million | 32.84 Million | 30.73 Million | 27.51 Million | 22.34 Million |
Deferred income taxes | 721 Thousand | 216 Thousand | -4.72 Million | 181.4 Thousand | 60 Thousand |
Stock-based compensation | 40.85 Million | 31.83 Million | 21.42 Million | 1.63 Million | 1.37 Million |
Change in working capital | -22.17 Million | -3.23 Million | -2.43 Million | 15.6 Million | -408 Thousand |
Other non-cash items | 457 Thousand | 10.91 Million | 85.98 Million | 12.18 Million | 8.38 Million |
Investing Cash Flow | 51.94 Million | -140.34 Million | -84.1 Million | -36.55 Million | -116.85 Million |
Investments in PPE | -18.3 Million | -27.8 Million | -18.32 Million | -12.04 Million | -9.25 Million |
Acquisitions | - | - | -46.08 Million | -19.82 Million | -105.83 Million |
Investment purchases | -273.99 Million | -385.02 Million | - | - | - |
Sales/Maturities of investments | 345.66 Million | 276.14 Million | - | - | - |
Other Investing Activities | -1.41 Million | -3.66 Million | -19.69 Million | -4.68 Million | -1.76 Million |
Financing Cash Flow | 290.84 Million | -1.72 Million | 1.56 Billion | 193.79 Million | 308.25 Million |
Debt repayment | -6.94 Million | -44.66 Million | -2.13 Million | -2.58 Million | -73.55 Million |
Dividends payments | - | - | - | - | - |
Common Stock Repurchased | - | - | -169 Million | -195.74 Million | -11.18 Million |
Common Stock Issuance | 3.8 Million | 3.01 Million | 627.98 Million | 301.73 Million | 247.81 Million |
Other Financing Activities | 293.98 Million | 42.94 Million | 1.11 Billion | 392.11 Million | 393 Million |
Accounts receivables | -8.28 Million | -10.28 Million | -4.71 Million | -5.71 Million | -2.32 Million |
Accounts payables | 2.86 Million | -3.38 Million | -12.37 Million | 14.14 Million | 3.66 Million |
Inventory | - | - | -3.1 Million | 9.75 Million | 2.28 Million |
Other working capital | -16.74 Million | 10.44 Million | 17.75 Million | -2.58 Million | -4.03 Million |
Cash at beginning of period | 350.56 Million | 1.8 Billion | 390.07 Million | 276.97 Million | 147.36 Million |
Cash at end of period | 406.97 Million | 1.63 Billion | 1.8 Billion | 390.07 Million | 276.97 Million |
Capital Expenditure | -18.3 Million | -27.8 Million | -18.32 Million | -12.04 Million | -9.25 Million |
Effect of forex changes on cash | -500.69 Million | - | - | - | - |
Net cash flow / Change in cash | 56.41 Million | -170.77 Million | 1.41 Billion | 113.1 Million | 129.61 Million |
Free Cash Flow | -9.85 Million | -56.5 Million | -86.99 Million | -56.17 Million | -71.04 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 436 Thousand | -1 Million | -4.47 Million | -47.32 Million | -8.09 Million | -18.77 Million |
Depreciation & Amortization | 9.2 Million | 9.3 Million | 9.39 Million | 35.91 Million | 9.05 Million | 8.87 Million |
Deferred income taxes | 89 Thousand | 89 Thousand | 563 Thousand | 721 Thousand | 53 Thousand | 52 Thousand |
Stock-based compensation | 12.31 Million | 10.95 Million | 9.67 Million | 40.85 Million | 11.22 Million | 11.02 Million |
Change in working capital | 3.23 Million | -26.17 Million | 3.68 Million | -22.17 Million | -5.83 Million | 7.11 Million |
Other non-cash items | 31.88 Million | 33.91 Million | 1.33 Million | 457 Thousand | -756 Thousand | 693 Thousand |
Investing Cash Flow | 3.26 Million | -59.54 Million | 51.72 Million | 51.94 Million | -3.27 Million | -40.68 Million |
Investments in PPE | -4.62 Million | -4.56 Million | -5.4 Million | -18.3 Million | -4.64 Million | -4.07 Million |
Acquisitions | - | - | 8.04 Million | - | -4.16 Million | -3.87 Million |
Investment purchases | -11 Million | -87.99 Million | -11 Million | -273.99 Million | -99.99 Million | -99.99 Million |
Sales/Maturities of investments | 22.33 Million | 33.66 Million | 68.23 Million | 345.66 Million | 101.72 Million | 64.02 Million |
Other Investing Activities | -3.43 Million | -656 Thousand | -8.15 Million | -1.41 Million | 3.8 Million | 3.24 Million |
Financing Cash Flow | -24.03 Million | -355.61 Million | 347.57 Million | 290.84 Million | 36.73 Million | 139.37 Million |
Debt repayment | -480 Thousand | -483 Thousand | -5.29 Million | -6.94 Million | -537 Thousand | -546 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 3.44 Million | 3.16 Million | 1.17 Million | 3.8 Million | 749 Thousand | 337 Thousand |
Other Financing Activities | -27 Million | -358.29 Million | 351.69 Million | 293.98 Million | 36.52 Million | 139.58 Million |
Accounts receivables | -1.21 Million | -2.44 Million | -6.06 Million | -8.28 Million | 2.49 Million | -1 Million |
Accounts payables | 50 Thousand | -1.42 Million | -1.81 Million | 2.86 Million | 1.75 Million | 2.94 Million |
Inventory | - | - | 4.09 Million | - | -8.44 Million | 4.35 Million |
Other working capital | 4.39 Million | -22.3 Million | 7.47 Million | -16.74 Million | -1.62 Million | 818 Thousand |
Cash at beginning of period | 343.66 Million | 406.97 Million | 339.93 Million | 350.56 Million | 1.52 Billion | 1.41 Billion |
Cash at end of period | 375.17 Million | 343.66 Million | 406.97 Million | 406.97 Million | 1.56 Billion | 1.52 Billion |
Capital Expenditure | -4.62 Million | -4.56 Million | -5.4 Million | -18.3 Million | -4.64 Million | -4.07 Million |
Effect of forex changes on cash | - | - | -352.44 Million | -500.69 Million | - | - |
Net cash flow / Change in cash | 31.51 Million | -63.31 Million | 67.04 Million | 56.41 Million | 39.1 Million | 107.67 Million |
Free Cash Flow | 20.65 Million | -10.91 Million | 14.78 Million | -9.85 Million | 1.01 Million | 4.91 Million |
CAR
APX
MED
AUEEF
8250
VIKASWSP